Drucker et al., Proc. Natl. Acad. Sci. USA, vol. 93, (1996), pp. 7911-7916.* |
Dayhoff, Atlas of Protein Sequence and Structure, vol. 5, p. 96.* |
Litvak et al 1998. “Glucagon-Like Peptide Is a Potent Growth Factor for Small Intestine and Colon.” Journal of Gastrointestinal Surgery 146-150. |
Mojsov, et al., “Preprogiucagon Gene Expression in Pancreas and Intestine Diversifies at the Level of Post-Translational Processing” The Journal of Biological Chemistry, (Sep. 5, 1986), vol. 261, No. 25, pp. 11880-11889. |
Ørskov, et al., “Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas”, Endocrinology, (1986), vol. 119, no. 4, pp. 1467-1475. |
Ørskov, et al., “Pancreatic and Intestinal processing of proglucagon in man”, Diabetologia, (1987), vol. 30, pp. 874-881. |
Ørskov, et al., “Carboxypeptidase-B-like processing of the C-24, terminus of glucagon-like peptide-2 in pig and human small intestine”, FEBS Letters, (Apr. 1989), vol. 247 No. 2, pp. 193-196. |
George, et al., “Molecular forms of glucagon-like peptides in Man”, FEBS Letters, (1985), vol. 192, No. 2, pp. 275-278. |
Hoosein, et al., “Human glucagon-like peptides 1 and 2 activate rat brain adenylate Cyclase”, FEBS Letters, (Dec. 1984), vol. 178, No. 1, pp. 83-86. |
Buhl, et al., “Naturally Occuring Products of Proglucagon 111-160 in the Porcine and Human Small Intestine”, The Journal of Biological chemistry, (Jun. 25, 1998), vol. 263, no. 18, pp. 8621-8624. |
M. Chasin, et al., “Biodegradable Polymers as Drug Delivery Stems”, Drugs and Pharmaceutical Sciences, (1990), vol. 45. |
Ørskov, et al., “Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2)”, Scand. J. Clin. Lab. Invest., (Apr. 1987), vol. 47, No. 2, pp. 165-174. |
Barragan, et al., “Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats”, American Journal of Physiology, (Mar. 1994), vol. 266, No. 3, Part 1, pp. E459-E466. |
Brubaker, et al., “Regulation of Intestinal Proglucagon-Derived Peptide Secretion by Intestinal Regulatory Peptides”, Endocrinology, (1991), vol. 128, No. 6, pp. 3175-3182. |
Calvo, et al., “Structural characterization by affinity cross-linking of Glucagon-like peptide-1(7-36) amide receptor in rat brain”, J. Neurochem., (Jan. 1995), vol. 64, No. 1, pp. 299-306. |
Cheeseman, et al., “The effect of gastric inhibitory polypeptide and glucagon like peptides on intestinal basolaterial membrane hexose transport”, The American Physiological Society. (Apr. 16, 1996), APSracts 3:0071G. |
Ehrlich, et al., “Inhibition of Pancreatic proglucagon gene expression in mice bearing subcutaneous endocrin Tumors”, America Journal of Physiology, (1994), pp. E662-E671. |
Irwin, et al., “Trout and Chicken Proglucagon: Alternative Splicing Generates mRNA Transcripts Encoding Glucagon-like Peptide 2”, Molecular Endocrinology, (1995), vol. 9, pp. 267-277. |
Drucker, “Glucagon and the Glucagon-like Peptides”, Pancreas, (1990), vol. 5, No. 4, pp. 484-488. |
Litvak et al. 1997. “Glucagon-Like Peptide 2: A Potent Intestinal Growth Factor.” Gastroenterology, 112:A1455. |